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A B S T R A C T
We present the case of a 29-year-old woman with right renal artery stenosis caused by ﬁbromuscular
dysplasia (FMD) who underwent optical coherence tomography (OCT)-guided percutaneous translum-
inal renal angioplasty. Using OCT, we could clearly observe intimal ﬁbroplasia and medial hyperplasia
that was indicative of FMD. Based on diagnosis of FMD by OCT, this patient was treated with plain old
balloon angioplasty that resulted in adequate luminal opening without intimal dissection conﬁrmed on
ﬁnal angiography and OCT.
<Learning objective: Fibromuscular dysplasia (FMD) is most often diagnosed based on its characteristic
appearance on angiography but it is insufﬁcient. Although pathological examination is needed for
deﬁnite diagnosis, it is not realistic. Therefore, it is important to assess the detailed intravascular ﬁndings
of culprit and non-culprit lesions in FMD with optical coherence tomography.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Fibromuscular dysplasia (FMD) is a noninﬂammatory and
nonatherosclerotic disease of medium-size arteries accounting for
10% of all causes of renovascular hypertension [1]. FMD is usually
seen in young women and can cause uncontrolled hypertension
that is often resistant to antihypertensive medication. Renovascu-
lar hypertension induced by FMD can be successfully treated by
surgical or catheter intervention. Percutaneous transluminal renal
angioplasty (PTRA) with or without stent placement has become
the preferred treatment [2]. However, it is often difﬁcult to
deﬁnitively diagnose FMD only by angiographic ﬁndings, especial-
ly to differentiate FMD from vasculitis [3]. Fundamentally, we need
to examine histological ﬁndings in detailed three layers of renal
artery for deﬁnite diagnosis of FMD. The high resolution of optical
coherence tomography (OCT) allows easy assessment of intravas-
cular characteristics and morphology [4]. In this case report, we
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A 29-year-old woman with a headache and hypertension
presented to our institution for evaluation of renovascular
hypertension.
Despite amlodipine and telmisartan treatment, her blood
pressure (BP) was uncontrolled [systolic BP (SBP): 156 mmHg,
diastolic BP (DBP): 80 mmHg]. The patient had no other risk factors
for atherosclerosis besides hypertension, and no family history of
FMD.
Contrast-enhanced computed tomography showed severe long
tubular stenosis in the middle of the right renal artery and
signiﬁcant loss of right renal mass compared with the left kidney
(Fig. 1A). In this patient, FMD in other vessels were not involved. As
this patient had a wish for babies, withdrawal of medication was
expected. Therefore, we decided to perform PTRA for the culprit
lesion, using both intravascular ultrasound (IVUS) and OCT for
guidance. We used the C7-XRTM OCT intravascular imaging system
(St. Jude Medical Inc., St. Paul, MN, USA). First, we assessed the
culprit lesion by angiography. We acquired right femoral access,
and performed angiography with a 6-French RDC catheter (Boston
Scientiﬁc, Natick, MA, USA). Angiography revealed a long tubular
stenosis in the middle of the renal artery, which was classiﬁed as
type 2 FMD (Fig. 1B). Continuously, IVUS catheter was pulled back
from distal to proximal region (Fig. 2A and C). It showed only reserved.
Fig. 1.
Contrast-enhanced computed tomography and renal angiography. (A) Severe stenosis at middle of right renal artery, and loss of right renal mass. (B) Long tubular
stenosis which was considered as type 2 by angiographical classiﬁcation of ﬁbromuscular dysplasia.
Fig. 2.
Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) ﬁndings of culprit and non-culprit lesion. There were no atherosclerotic and
ﬁbromuscular changes in non-stenotic lesions (A, C, D and F). IVUS showed only thickening of intima-media complex (B). On the other hand, using OCT, intimal
ﬁbroplasia and medial hyperplasia could be visualized in culprit lesion (E).
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that could not be assessed qualitatively (Fig. 2B). Additionally, the
OCT catheter was positioned such that its imaging lens was distal
to the culprit lesion. After catheter placement, a cardiovascular
injection pump was used for contrast medium ﬂush through the
guide catheter at a rate of 5 mL/s for a total of 20 mL. OCT showed
intimal ﬁbroplasia and medial hyperplasia. Especially in media, the
inside was homogeneous and low intensity (Fig. 2E).
On the other hand, no atherosclerotic or ﬁbromusucular
changes were noted in the nonstenotic lesions (Fig. 2D and F). A
uniform classiﬁcation system to describe FMD of the renal artery
was proposed by Harrison and McCormack at the Cleveland and
Mayo Clinic reported in 1971 [5]. Using this classiﬁcation, we
described the OCT ﬁndings as intimal ﬁbroplasia and medial
hyperplasia, which agree with the angiographic ﬁnding concentric,
long smooth narrowing.
Based on OCT ﬁndings, we performed plain old balloon
angioplasty without a stent for this lesion. The procedure was
performed using a femoral access and monorail balloon catheter
(Boston Scientiﬁc) through a 0.014-inch wire platform. Adequate
opening was achieved using a 4.0 mm  15 mm-sized balloon
(Fig. 3A and B), as seen on quantitative coronary angiography;
minimum lumen diameter increased from 0.8 mm to 3.0 mm, and
percentage of diameter stenosis decreased from 89% to 17%. OCT
revealed satisfactory exclusion of media, with no intimal dissection
(Fig. 3D), although IVUS showed only luminal expansion (Fig. 3C).
OCT allowed evaluation of the FMD lesion. One month post
PTRA, the patient’s blood pressure had considerably decreasedFig. 3.
Optical coherence tomography (OCT)-guided percutaneous transluminal renal
made successful outcome. (C) Sufﬁcient luminal expansion in intravascular u
OCT imaging.(SBP 130 mmHg, DBP 72 mmHg) without antihypertensive medi-
cation. Although this patient was just followed up by clinical
ﬁndings, hypertension did not recur during follow-up period
(481 days), and she gave birth without any problems after one year
post PTRA.
Discussion
Sa´nchez-Recalde et al. recently reported FMD that appeared as
beads on OCT [6]. In addition to a previous report, our report is
among the ﬁrst to describe the usefulness of OCT for FMD diagnosis
and evaluation of before and after PTRA.
The most common arterial bed, affected by FMD is the renal
arteries, followed by the internal carotid arteries and iliac arteries
[7]. In contrast to atherosclerotic renal artery disease, renal artery
FMD is rarely associated with loss of renal function, although loss
of renal mass can occur in up to 63% of patients. Progression of
stenosis can occur in up to 37% of patients, although renal artery
occlusion with subsequent renal infarction is rare, which
prompted the selection of medical treatment instead of interven-
tion [1]. FMD is most often diagnosed based on its clinical
background and characteristic appearance of angiography, but it is
incorrect especially in focal or long tubular stenotic pattern.
Furthermore, it has been mentioned that it is difﬁcult to
differentiate diffuse intimal FMD from vasculitis. If histological
proof of FMD or inﬂammation is not available, distinguishing these
entities may at times be difﬁcult because the angiographic
appearance can be similar. This is most often the case in the angioplasty. (A and B) Plain old balloon angioplasty to culprit lesion without stent
ltrasound imaging. (D) Enough exclusion of media, and no-dissection at intima in
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examination can be used for deﬁnite diagnosis, it is rarely
performed. Therefore, it is important to assess the detailed
intravascular ﬁndings of culprit and non-culprit lesion in FMD
with OCT. We often use OCT for coronary artery intervention. The
resolution of the OCT image is 10–15 mm, which is 10 times the
resolution of the IVUS image (100–200 mm). Several studies have
reported that the intimal thickness could be evaluated by OCT and
correlated well with the histological examination results [8]. In
contrast, other studies have showed the different ﬁndings between
histology and intravascular imaging such as IVUS, OCT, or coronary
angioscopy [9]. Therefore, it may be controversial whether OCT
ﬁndings are in agreement with histological ﬁndings. However,
using OCT, we can observe three layers of arteries in detail,
although IVUS cannot provide the information regarding differ-
ence between intima and media. On the other hand, because it is
not suitable for viewing distant objects (observation depth: 2 mm),
it is rarely used to visualize middle- to large-sized arteries (vessel
diameter 5 mm), including the renal artery. In the present report,
although it was challenging, we attempted to use C7-XRTM OCT
intravascular imaging system (second-generation Fourier-domain
OCT system) for detailed evaluation of an FMD lesion with
sufﬁcient contrast medium ﬂush by using auto-injector. Using OCT,
we could clearly assess medial hyperplasia and intimal ﬁbroplasia,
which conﬁrmed the diagnosis of FMD.
PTRA without stent is the most widely accepted and initial
treatment of choice for patients with FMD. Efﬁcacy of PTRA for
FMD has been reported in previous studies [10]. In this case, we
could safely perform OCT-guided PTRA using only a balloon.
OCT may be instrumental for both deﬁnite diagnosis and
assessment of the efﬁcacy of PTRA for FMD.
In conclusion, OCT-guided PTRA allowed deﬁnite diagnosis of
FMD because the OCT images could show detailed ﬁndings of three
layers of renal artery. Furthermore, OCT ﬁndings provided us
sufﬁcient therapeutic effect after PTRA despite middle-sized
artery. Our report suggests that OCT is useful for diagnosis and
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